Sneha Anand

Sneha is currently a postdoctoral scientist in the Cellular High Content Imaging Group led by Daniel Ebner at the Target Discovery Institute (TDI), Centre for Medicines Discovery, University of Oxford. Sneha is responsible for cell-based high-throughput functional genomic screens. Before joining TDI, Sneha worked in Prof. Terry Rabbitt’s group at University of Oxford, where she worked on establishing technologies to target cellular protein function using antibody fragments as drug surrogates. She has experience developing specific and potent reagents to study cancer development and drug-like molecules as leads for therapeutic drug development. Sneha also holds a PhD in infection biology focusing on vaccine development for infectious diseases.